Luisa Poggi

Title: Luisa Poggi: Innovator in Nucleic Acid Aptamers

Introduction

Luisa Poggi is a distinguished inventor based in Banchette d'Ivrea, Italy. She has made significant contributions to the field of nucleic acid aptamers, with a focus on their diagnostic and therapeutic applications. With a total of 3 patents to her name, Poggi's work is paving the way for advancements in medical diagnostics and treatments.

Latest Patents

Among her latest patents, Luisa Poggi has developed innovative nucleic acid aptamers that bind to the Carbonic Anhydrase IX (CA-IX) enzyme. This invention provides valuable diagnostic tools for imaging organs and tissues that express CA-IX, as well as therapeutic agents for the prevention or treatment of CA-IX related diseases. Another notable patent involves aptamers binding to the Intercellular Adhesion Molecule-1 (ICAM-1), which also serves as diagnostic tools and therapeutic agents for ICAM-1-related diseases.

Career Highlights

Luisa Poggi is currently associated with Bracco Imaging S.p.A., where she continues to advance her research in aptamer technology. Her work has garnered attention for its potential to revolutionize diagnostic imaging and therapeutic strategies in medicine.

Collaborations

Throughout her career, Poggi has collaborated with esteemed colleagues, including Alessandro Maiocchi and Vittorio De Franciscis. These partnerships have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Luisa Poggi's contributions to the field of nucleic acid aptamers exemplify her commitment to innovation in medical science. Her patents not only enhance diagnostic capabilities but also offer new therapeutic avenues for treating diseases.